Skip to main content
OpenTrials

Clinical trial condition

Endocrine System Diseases

Explore clinical trials studying Endocrine System Diseases. Study availability and eligibility vary by location and protocol.

26,440 public trials 3,595 recruiting studies
Refine in advanced search Browse all conditions

Endocrine System Diseases trial results

Active, Not Recruiting

GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery

NCT00878163

Conditions
Adult Solid Neoplasm, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Pentoxifylline in Diabetic Kidney Disease

NCT03625648

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Kidney Disease, +8 more
Locations
  • Phoenix VA Health Care System, Phoenix, AZ Phoenix, Arizona, United States
  • Central Arkansas Veterans Healthcare System, Little Rock, AR Little Rock, Arkansas, United States
  • VA Loma Linda Healthcare System, Loma Linda, CA Loma Linda, California, United States
  • VA Long Beach Healthcare System, Long Beach, CA Long Beach, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®

NCT05230550

Conditions
Adult Growth Hormone Deficiency, Bone Diseases, Bone Diseases, Developmental, +11 more
Locations
  • Ikeda Hospital_Diabetes Medicine Amagasaki-shi, Hyogo, Japan
  • University of Yamanashi Hospital Chuo-shi, Yamanashi-ken, Japan
  • Fukuoka University Chikushi Hospital_Endocrinology and Diabetes Mellitus Fukuoka, Japan
  • Kurume University Hospital Fukuoka, Japan
View all 47 locations
View Trial Details
Active, Not Recruiting

ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer

NCT05446298

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • Cancer Treatment Centers of America, Phoenix. 403 Goodyear, Arizona, United States
  • Honor Health, USOR, 406 Phoenix, Arizona, United States
  • Nuvance Health System, 401 Danbury, Connecticut, United States
  • Baptist MD Anderson Cancer Center, 404 Jacksonville, Florida, United States
View all 21 locations
View Trial Details

Related conditions